Direkt zum Inhalt
Merck

Fortfahren mit

8.52057

Fmoc-Lys(Dde)-OH

≥98% (TLC), for peptide synthesis, Novabiochem®

Synonym(e):

Fmoc-Lys(Dde)-OH, N-α-Fmoc-N-ε-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-lysine

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis

Über diesen Artikel

Empirische Formel (Hill-System):
C31H36N2O6
CAS-Nummer:
Molekulargewicht:
532.63
MDL number:
UNSPSC Code:
12352209
NACRES:
NA.22
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Produktname

Fmoc-Lys(Dde)-OH, Novabiochem®

Quality Level

product line

Novabiochem®

assay

≥90.0% (acidimetric), ≥97.0% (HPLC), ≥98% (TLC)

form

powder

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

manufacturer/tradename

Novabiochem®

mp

80 °C (decomposes)

application(s)

peptide synthesis

functional group

amine

storage temp.

−20°C

InChI

1S/C31H36N2O6/c1-19(28-26(34)16-31(2,3)17-27(28)35)32-15-9-8-14-25(29(36)37)33-30(38)39-18-24-22-12-6-4-10-20(22)21-11-5-7-13-23(21)24/h4-7,10-13,24-25,34H,8-9,14-18H2,1-3H3,(H,33,38)(H,36,37)/t25-/m0/s1

InChI key

AOHSSQNORWQENF-VWLOTQADSA-N

General description

Quasi-orthogonally-protected Lys derivative for Fmoc SPPS. The Fmoc group can be removed selectively by treatment with piperidine; the Dde group is cleaved with 2% hydrazine in DMF [1]. When removing Dde in the presence of allyl based protecting groups, allyl alcohol should be included in the deprotection solution to prevent reduction of the allyl group [2].Lys(Dde) has been employed in the following applications: synthesis of branched peptides [1] and di-epitopic peptides [3]; preparation of MAP core molecules and lipo-MAPs [4,5]; construction of cyclic peptides [6], TASP molecules [7], templates for combinatorial chemistry [8] and synthetic proteins [9]; preparation of peptides modified at the lysine side-chain [10,11,12,13,14].It has been reported that Dde can migrate from the side-chain of Lys to the unprotected side-chain of another Lys residue [15], and from the β-amino group to the α-amino group of Dpr [16]. In the former instance, this problem can be overcome by using Fmoc-Lys(ivDde)-OH (852082) or using DBU/DMF (2:98) for Fmoc group removal [15,17].Full orthogonality of Dde with Fmoc has recently been demonstrated when hydroxylamine is used for Dde removal [18].

Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS

Literature references

[1] B. W. Bycroft, et al. (1993) J. Chem. Soc., Chem. Commun., 778.
[2] B. Rohwedder, et al. (1998) Tetrahedron Lett., 39, 1175.
[3] N. Ahlborg (1995) J. Immun. Meth., 179, 269.
[4] B. W. Bycroft, et al. in ′Peptides, Chemistry, Structure & Biology, Proc. 13th American peptide Symposium′, R. S. Hodges & J. A. Smith (Eds), ESCOM, Leiden, 1994, pp. 727.
[5] J. Mack, et al. (2001) J. Peptide Sci., 7, 338.
[6] G. B. Bloomberg, et al. (1993) Tetrahedron Lett., 34, 4709.
[7] P. Dumy, et al. (1995) Tetrahedron Lett., 36, 1255.
[8] J. Eichler, et al. (1994) Pept. Res., 7, 300.
[9] C. G. Fields, et al. (1993) Biopolymers, 33, 1695.
[10] H. F. Brugghe, et al. (1994) Int. J. Peptide Protein Res., 43, 166.
[11] P. Hoogerhout, et al. (1995) Infection & Immunity, 63, 3473.
[12] D. Lelievre, et al. (1995) Tetrahedron Lett., 36, 9317.
[13] P. Hoogerhout, et al. (1999) J. Peptide Res., 54, 436.
[14] P.J. Conolly, et al. (2000) Tetrahedron Lett., 41, 5187.
[15] K. Augustyns, et al. (1998) J. Peptide Res., 51, 127.
[16] A. Srinivasan, et al., Poster 111 presented at the 15th American Peptide Symposium, Nashville, 1997.
[17] S. Peluso, et al. (1999) J. Org. Chem., 64, 7114.
[18] J. J. Diaz-Mochón, et al. (2004) Org. Lett., 6, 1127.

Analysis Note

Colour (visual): white to slight yellow to beige
Appearance of substance (visual): powder
Identity (IR): passes test
Enantiomeric purity: ≥ 99.5 % (a/a)
Purity (TLC(157B)): ≥ 98 %
Purity (TLC(CMA2)): ≥ 98 %
Assay (HPLC, area%): ≥ 97.0 % (a/a)
Solubility (1 mmole in 2 ml DMF): clearly soluble
Assay (acidimetric): ≥ 90.0 %
Water (K. F.): ≤ 1.0 %

To see the solvent systems used for TLC of Novabiochem® products please click here.

Other Notes

Replaces: 04-12-1121

Legal Information

Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
8.521478.540008.52082
form

powder

form

powder

form

powder

form

powder

functional group

amine

functional group

amine

functional group

amine

functional group

amine

assay

≥90.0% (acidimetric), ≥98% (TLC), ≥97.0% (HPLC)

assay

≥95.0% (acidimetric), ≥98% (TLC), ≥98.0% (HPLC)

assay

≥90.0% (acidimetric), ≥96.0% (HPLC), ≥97% (TLC)

assay

≥85.0% (acidimetric), ≥97% (TLC), ≥99.0% (HPLC)

product line

Novabiochem®

product line

Novabiochem®

product line

Novabiochem®

product line

Novabiochem®

storage temp.

−20°C

storage temp.

15-25°C

storage temp.

15-25°C

storage temp.

-10 to -25°C

mp

80 °C (decomposes)

mp

135-145 °C

mp

>70 °C (decomposition)

mp

-


Lagerklasse

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable



Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen


Artikel

Novabiochem® offers orthogonally protected amino acids for peptide synthesis, including cyclic and branched peptides.





Global Trade Item Number

SKUGTIN
852057000104027269087562
852057010004027269688813
852057002504027269688820
852057000504027269087579

Questions

Reviews

No rating value

Active Filters